Watari, Hiromi http://orcid.org/0000-0002-6532-2508
Kageyama, Hiromu
Masubuchi, Nami
Nakajima, Hiroya
Onodera, Kako
Focia, Pamela J. http://orcid.org/0000-0003-0698-7996
Oshiro, Takumi
Matsui, Takashi http://orcid.org/0000-0002-4496-2389
Kodera, Yoshio
Ogawa, Tomohisa http://orcid.org/0000-0001-8700-6330
Yokoyama, Takeshi
Hirayama, Makoto
Hori, Kanji
Freymann, Douglas M. http://orcid.org/0000-0002-5231-8841
Imai, Misa
Komatsu, Norio
Araki, Marito http://orcid.org/0000-0002-3502-5000
Tanaka, Yoshikazu
Sakai, Ryuichi http://orcid.org/0000-0001-6490-0495
Funding for this research was provided by:
MEXT | Japan Society for the Promotion of Science (22K20589, 20J11377, 21K08405, 21K08376, 21K08424, 19K08848, 22H02252, 22H02915, 19H03040, 22H02430)
Ikeda Scientific Co. Ltd. Suntory foundation for life science
Senshin Medical Research Foundation Takeda Science Foundation
Article History
Received: 19 March 2022
Accepted: 7 November 2022
First Online: 25 November 2022
Competing interests
: Araki and Imai are employees of Meiji Seika Pharma, and Komatsu has received a salary from Pharmaessentia Japan where he is a board member. The remaining authors declare no other competing interests.